Archive | HAPILA GmbH
HAPILA extends role in ATHANA nanoparticle antifungal alliance to regulatory support
Wednesday 8th January 2025
Learn More >
HAPILA teams with Transo-Pharm to present end-to-end API expertise at CPHI Milan
Tuesday 17th September 2024
Learn More >
HAPILA brings advanced API and synthesis capabilities to Chemspec Europe 2024
Tuesday 11th June 2024
Learn More >
HAPILA bringing end-to-end API supply chain solutions to CPHI Barcelona
Friday 20th October 2023
Learn More >
HAPILA and ATHANA alliance receive funding for nanoparticle antifungal program
Wednesday 13th September 2023
Learn More >
HAPILA’s co-developed anti-TB agent BTZ-043 named ‘Drug of the Year’
Friday 8th September 2023
Learn More >
HAPILA shows advanced API development capabilities at Chemspec Europe 2023
Thursday 11th May 2023
Learn More >
HAPILA commences cGMP pilot scale manufacture of anti-TB API BTZ-043
Wednesday 16th November 2022
Learn More >